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Abstract
Semen is a major vector for HIV transmission, but the semen HIV RNA viral load (VL) only correlates moderately with the
blood VL. Viral shedding can be enhanced by genital infections and associated inflammation, but it can also occur in the
absence of classical pathogens. Thus, we hypothesized that a dysregulated semen microbiome correlates with local HIV
shedding. We analyzed semen samples from 49 men who have sex with men (MSM), including 22 HIV-uninfected and 27
HIV-infected men, at baseline and after starting antiretroviral therapy (ART) using 16S rRNA gene-based pyrosequencing and
quantitative PCR. We studied the relationship of semen bacteria with HIV infection, semen cytokine levels, and semen VL by
linear regression, non-metric multidimensional scaling, and goodness-of-fit test. Streptococcus, Corynebacterium, and
Staphylococcus were common semen bacteria, irrespective of HIV status. While Ureaplasma was the more abundant
Mollicutes in HIV-uninfected men, Mycoplasma dominated after HIV infection. HIV infection was associated with decreased
semen microbiome diversity and richness, which were restored after six months of ART. In HIV-infected men, semen
bacterial load correlated with seven pro-inflammatory semen cytokines, including IL-6 (p = 0.024), TNF-a (p = 0.009), and IL1b (p = 0.002). IL-1b in particular was associated with semen VL (r2 = 0.18, p = 0.02). Semen bacterial load was also directly
linked to the semen HIV VL (r2 = 0.15, p = 0.02). HIV infection reshapes the relationship between semen bacteria and proinflammatory cytokines, and both are linked to semen VL, which supports a role of the semen microbiome in HIV sexual
transmission.
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bacterial pathogens, such as Chlamydia trachomatis and Neisseria
gonorrhoeae [12] have been associated with increased semen VL
in untreated men. These pathogens are thought to act directly
through interaction with HIV-infected CD4+ T-cells [13,14] or
indirectly by local immune activation and recruitment of HIV
susceptible cells to the genital mucosa [9–12].
However, in HIV-infected men who have sex with men (MSM)
on suppressive antiretroviral therapy (ART), T cell activation in
the semen has been associated with transient bursts of semen viral
replication, in the absence of classical sexually transmitted
infections and independent of cytomegalovirus reactivation or
herpes infection [6]. There is also evidence that increased
proinflammatory cytokine and chemokine in the semen might
enhance local HIV replication and evolution in the male genital
tract [15]. Together, these findings highlight that compartmentalized factors within the male genital tract could cause immune

Introduction
Semen is an important vector in the sexual transmission of HIV
[1], and the risk of transmission increases with the semen HIV
RNA viral load (VL) [2,3]. The semen VL is more variable over
time than that of blood, and the two are only moderately
correlated [4–8]. Therefore, since the semen HIV VL is an
independent predictor of HIV transmission risk [3], a better
understanding of the local factors that trigger or increase HIV
shedding in the semen could enable novel interventions to reduce
HIV sexual transmission.
Many viral and bacterial pathogens are known to increase HIV
shedding in men. Specifically, local reactivation and replication in
the genital tract of persistent herpes viruses, such as Cytomegalovirus, Epstein-Barr virus, and Herpes Simplex virus types 1 and
2 [9–11], as well as infection by classical sexually transmitted
PLOS Pathogens | www.plospathogens.org
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Prior to ART initiation, all 27 HIV-infected participants had
detectable HIV-1 RNA in the blood and semen. In addition, the
blood VL correlated positively with the semen VL (r2 = 0.27,
p = 0.003); however, while the blood CD4+ T-cell count correlated
negatively with the blood VL (r2 = 0.27, p = 0.003), it showed no
significant association with semen VL (Figure S1). The clinical
response to ART was excellent. After one month of treatment,
viral RNA was only detectable in the semen of seven men and in
the blood of 15 men, which further decreased to only one and two
men, respectively, after six months of ART. Concurrently, the
blood CD4+ T-cell count increased to a median of 360 cells/mm3
after one month of ART (Range = 100–910) and to 450 cells/mm3
after six months of ART (Range = 275–940).

Author Summary
The classical paradigm of HIV infectivity centers on the
blood HIV RNA viral load. However, while other fluid
compartments such as semen and cerebrospinal fluid can
have distinct viral loads from blood, the causes of localized
HIV shedding are not fully understood. Since the semen
viral load is an independent predictor of HIV transmission
risk, it is critical to understand the local factors that trigger
increased semen viral shedding in order to develop novel
preventative strategies. Here, we evaluated the semen
microbiome, bacterial load, and cytokine levels in 22 HIVuninfected men who have sex with men (MSM) and in 27
HIV-infected MSM before and after initiation of antiretroviral therapy (ART). We found that HIV infection reduces
semen microbiome biodiversity, which is restored with
ART and immune reconstitution. We also found that
semen bacterial load in untreated, HIV-infected men is
associated with the levels of seven semen cytokines,
relationships not seen in the uninfected controls. In
particular, the cytokine IL-1b was uniquely correlated with
both semen bacterial and viral load. Our findings support
the interaction between semen microbiome and local
immunology, and suggest that IL-1b could be a mechanism for semen microbiome to trigger semen viral
shedding.

Semen bacteria in HIV-uninfected participants
In HIV-uninfected MSM, Streptococcus, Corynebacterium, and
Staphylococcus were among the most prevalent and proportionally
abundant semen bacteria. Other bacteria that were proportionally
abundant and comprised of 1–3% of the semen microbiota
included Prevotella, Porphyromonas, Finegoldia, Micrococcus, and
Actinomyces (Figure 1A, Table 2, Table S1 in Text S1). While
Ureaplasma was only seen in four men, it comprised of a large
portion of the semen microbiome in these individuals (Figure 1A,
Table 2, Table S1 in Text S1). We detected a total of 248
unique semen bacterial genera, though not all were seen in all
men. On average, 71 distinct semen bacterial genera were found
in each man (SD = 27).
There was substantial variation in semen microbiome (Figure
S2) and semen bacterial load among the HIV-uninfected men
(Mean = 5.05 log10 16S rRNA gene copies per ml of semen,
Range = ,3.6 log10–7.11 log10). Despite this, we found that there
was a significant correlation between the semen microbiota
composition and semen bacterial load within an individual
(r = 0.31, p = 0.01) (Figure S3A).

activation in the semen and are responsible for subsequent
increases in HIV shedding.
In addition to spermatozoa, the semen contains nutrients,
numerous immune factors, and communities of bacteria [16–18].
Studies of infertility have shown a wide range of bacteria in the
semen [16,17,19], including those hypothesized to cause inflammatory obstructive processes in the male genital tract, such as
Chlamydia, Ureaplasma, and Mycoplasma [20,21]. The semen
microbiome in heterosexual men exhibits high prevalence and
abundance of commensals, such as Ralstonia, Anaerococcus and
Corynebacterium, as well as bacteria abundant in the vagina, such
as Prevotella and Lactobacillus [19].
This study aimed to determine how HIV infection and
suppressive ART impact the semen microbiome, and whether
the semen microbiome might be associated with inflammation and
the VL in semen. We hypothesized that the semen bacterial
microbiome represents an important cause of local immune
activation, and that this might contribute to the high degree of
variability in semen HIV levels. To test this hypothesis, we
compared the semen bacteria in 22 HIV-uninfected MSM
controls versus 27 HIV-infected, treatment-naı̈ve MSM, and we
further examined the semen bacteria in the latter group at one and
six months after antiretroviral therapy initiation.

Impact of HIV and antiretroviral treatment on the semen
microbiome and bacterial load
HIV infection did not significantly impact semen microbiome,
but the restoration of immunity by ART modified the relationship
between semen microbiome and CD4+ T-cell count. The semen
bacterial load of treatment-naı̈ve, HIV-infected men (Mean = 4.6
log10 copies/ml, Range = ,3.6 log10–6.52 log10 copies/ml) did not
differ significantly from uninfected controls Mean = 5.05 log10 16S
rRNA gene copies per ml of semen, Range = ,3.6 log10–7.11
log10; p = 0.13). Likewise, the initiation of ART did not
significantly impact semen bacterial load.
Streptococcus was the most common bacterium in semen,
irrespective of HIV infection status (Table 2, Table S1 in Text
S1). The semen microbiome composition had several distinct features
in association with HIV infection (Table S2 in Text S1), but its
overall composition was not affected significantly (PerMANOVA
p = 0.30). In uninfected controls, Ureaplasma was the dominant
Mollicute, with Ureaplasma parvum was the primary sequence type.
Mycoplasma dominated in HIV-infected men, with an average
proportional abundance of 6.7%, in contrast to 0.03% in uninfected
controls. With ART, the proportional abundance of Mycoplasma
decreased over time in the HIV-infected men (Figure 1B–D, Table
S1 in Text S1). Other semen bacteria also decreased after HIV
infection, including Pseudonocardia, Enhydrobacter, Bifidobacterium,
among others, while Peptostreptococcus and Actinomycetospora were
uniquely prevalent and abundant in the ART-naı̈ve men (Table S2
in Text S1).
A new relationship between the semen microbiome and
host immunity emerged after ART. Prior to ART, the semen

Results
Study participants
We enrolled 27 HIV-infected, ART-naı̈ve men and 22 HIVuninfected control men. All participants were men who have sex
with other men (MSM) and the ages of HIV-infected and
uninfected men were similar (HIV-infected Mean = 36.4 years;
HIV-uninfected Mean = 34.0 years, p = 0.399). Among the HIVinfected men, the baseline seroprevalences of HSV-2 and CMV
were 48.3% and 79.3%, respectively. The baseline CD4+ T-cell
count was 300 cells/mm3 (Range = 60–610), with median HIV-1
RNA loads of 30,122 copies/ml in blood (Range = 435–500,000)
and 3,192 copies/ml in semen (Range = ,300–208,152)
(Table 1).
PLOS Pathogens | www.plospathogens.org
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had a significantly lower semen microbiome diversity (DMean =
20.5, 95% CI = [20.03, 20.95]) (Figure 2A), representing an
average loss of nearly 16 genera (SMean = 215.8, 95% CI = [22.8,
228.4]) (Figure 2B). However, one aspect of semen microbiome
biodiversity that remained unchanged after HIV infection was the
equitability of bacterial constituents (EMean = 20.0006, 95%
CI = [20.007, 0.005]).
As ART restored CD4+ T-cell counts, the number of unique
semen bacteria increased, (Repeated Measures ANOVA,
p = 0.027), accompanied by restoration of semen microbiome
diversity (Repeated Measures ANOVA, p = 0.081) (Figure 2A).
After 6 months of ART, the semen richness increased by 11
genera (95% CI, 3.0 to 19.7) and the Shannon Diversity index had
increased by 0.41 (95% CI 0.04 to 0.75); at this point, the semen
microbiome biodiversity became statistically indistinguishable
from that of uninfected controls (Figure 2A–B). This restitution
of microbiome biodiversity with improved host immunity further
supports the role of host immunity in regulating bacteria in the
semen.
Notably, the increase in biodiversity was not driven by the
reappearance by bacteria that defined the HIV-uninfected state.
Rather, distinct bacteria, such as Pedobacter, showed a significant
proportional increase at 6 months of ART (Table S3 in Text
S1). In contrast, semen bacteria associated with HIV-uninfected
men showed only modest increase, with Enhydrobacter peaking
after one month of ART and Pseudonocardia peaking six months
of ART. Bifidobacterium showed no appreciable increase (Figure
S4, Table S2 in Text S1).

Table 1. Clinical parameters of the HIV-positive participants
at baseline, prior to initiation of antiretroviral therapy.

ART-naı̈ve men (n = 27)

n (%)
Age
21–29

3 (11.1)

30–39

17 (63.0)

40–49

6 (22.2)

$50

1 (3.7)

HSV-2 co-infection
Yes

13 (48.1)

No

14 (51.9)

CMV co-infection
Yes

24 (88.9)

No

1 (3.7)

Unknown

2 (7.4)

Absolute CD4+ T-cell count (/mm3)
,200

4 (14.8)

200–299

9 (33.3)

300–399

6 (22.2)

400–499

5 (18.5)

$500

3 (11.1)

CD4:CD8 T-cell Ratio
,0.25

6 (22.2)

0.25–0.50

14 (51.9)

.0.50

6 (22.2)

Unknown

1 (3.7)

Semen bacterial load and cytokine levels prior to ART
We hypothesized that, in HIV-infected men, the semen
bacterial load would correlate with pro-inflammatory cytokine/
chemokine levels in the semen. Our data supported the
hypothesis, revealing a markedly reorganized relationship between semen bacterial load and cytokines after HIV infection. In
uninfected controls, our data showed no correlation between
semen bacterial load and cytokine levels. However, in HIVinfected men, seven out of the 13 semen cytokines correlated with
semen bacterial load, and specifically, for each 10% increase in
semen bacterial load, there was a corresponding 2% increase in
MIG (p = 0.03), IL-10 (p = 0.02), IL-6 (p = 0.024), IP-10 (p
= 0.03), IL-17 (p = 0.03) and TNF-a (p = 0.009) and a 3%
increase in IL-1b (p = 0.002).
Using principal component analysis, we found that the seven
semen cytokines could be collapsed into three orthogonal
(independent) components, with the first component being driven
by IL-6, IL-17, IP10, and TNF-a, the second component by IL1b, and third component by MIG. IL-10 contributed to all three
(Table S4 in Text S1). Among the three components, only the
second (IL-1b) correlated significantly with semen HIV RNA VL
(r2 = 0.18, p = 0.02).
The correlations between IL-1b and both semen bacterial
load and semen HIV RNA VL could not be explained by
natural patterns in cytokine variation. There was considerable
heterogeneity in semen cytokine levels, with an inter-individual
range for most cytokines exceeding 2 log10 pg/ml, and median
levels ranging from 0.3 log10 pg/ml (IL-10) to 3.8 log10 pg/ml
(IP-10). However, neither the degree of variability nor the
median levels of cytokines related to semen bacterial or viral
load.
Further analysis did not reveal significant associations between
specific semen bacteria and local semen immunology, beyond the
associations already described with semen bacterial load. While
the total semen bacterial load correlated with pro-inflammatory

Blood viral load (log10 RNA copies/mL)
,4

8 (29.6)

4–4.9

11 (40.7)

$5

8 (29.6)

Semen viral load (RNA copies/mL)
,4

19 (70.4)

4–4.9

6 (22.2)

$5

2 (7.4)

doi:10.1371/journal.ppat.1004262.t001

microbiome composition, represented by the ordination score
matrix from non-metric multidimensional scaling, was correlated
with semen bacterial load (r = 0.45, p = 0.004) (Figure S3A).
However, after month one of ART, this initial correlation was lost
(Figure S3A), and after six months of ART, the semen
microbiome composition became correlated with the CD4+ Tcell count (r = 0.24, p = 0.03) (Figure S3B). Thus, as ART
restored immunity, individuals with higher CD4+ T-cell counts
had significantly different semen microbiome from those with
lower CD4+ T-cell counts. This suggests that restored CD4mediated immunity might shape the semen microbiome among
HIV-infected individuals (Figure S3).

HIV infection and the semen microbiome biodiversity
Another effect of ART was the reconstitution of semen
microbiome biodiversity, as illustrated by microbiome diversity
(D), richness (S), and evenness (E). Untreated HIV-infected men
PLOS Pathogens | www.plospathogens.org
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Figure 1. Rank abundance and the five most abundant semen bacteria in uninfected versus HIV-infected men over the course of
antiretroviral treatment. In this rank abundance plot, richness is the distance the plot extends along the x-axis, and evenness is low slope. Extreme
dominance is a high y-intercept. HIV uninfected is both richer and more even than the ART- naı̈ve, but by 6 months ART, the relationship converges
onto the HIV uninfected. The five top-ranked semen bacteria from each group are listed, with its respective group-level proportional abundance in
parenthesis.
doi:10.1371/journal.ppat.1004262.g001

or blood CD4+ T-cell count (r2 = 0.01, p = 0.28) (Figure 3C). The
rapid drop in semen viral load after ART initiation did not permit
assessment of the association between semen bacterial load and
HIV shedding in men treated with ART.
Since the semen HIV RNA VL was also positively correlated
with the blood VL, a multivariable logistic regression model was
used to assess the independent association of semen HIV levels
with blood VL and total semen bacterial load. To increase our
statistical power in the multivariate model, we assessed the total
bacterial load in an additional 22 HIV-infected, ART-naı̈ve MSM
participants (median CD4+ T count 410 cells/mm3, blood HIV-1
RNA load 43,008 copies/ml, and semen HIV-1 RNA load 6,168
copies/ml). In this larger dataset, the semen RNA VL remained

cytokine levels in the semen of HIV-infected men, this finding
reflects the individualized nature of the semen microbiome in both
HIV-infected and uninfected men.

Semen bacterial load and HIV viral load prior to in ARTnaı̈ve men
We also found that semen bacterial load was directly and
significantly correlated with semen HIV RNA levels prior to ART
initiation. Specifically, with each 10% increase in semen bacterial
load, semen viral load increased by 3% (r2 = 0.15, p = 0.02)
(Figure 3A). In contrast, the semen bacterial load was not
correlated with blood viral load (r2 = 0.07, p = 0.10) (Figure 3B)
PLOS Pathogens | www.plospathogens.org
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Table 2. Prevalence and proportional abundances of the 40 most prevalent semen bacteria in uninfected men and HIV-infected
men prior to initiation of antiretroviral therapy.

HIV-infected, ARTNaı̈ve (n = 27)

HIV-uninfected (n = 22)

Prevalence (%)

HIV-uninfected (n = 22)

HIV-infected, ARTNaı̈ve (n = 27)

Mean Proportional Abundance (SD)

Ureaplasma

4 (18.2%)

5 (18.5%)

0.0654 (0.2157)

0.0498 (0.1763)

Mycoplasma

4 (18.2%)

5 (18.5%)

0.0003 (0.0012)

0.067 (0.2182)

Streptococcus

22 (100%)

26 (96.3%)

0.0664 (0.0873)

0.0742 (0.1577)

Corynebacterium

22 (100%)

27 (100%)

0.0359 (0.0791)

0.0229 (0.0369)

Staphylococcus

21 (95.5%)

21 (77.8%)

0.0294 (0.0536)

0.0292 (0.0443)

Delftia

21 (95.5%)

20 (74.1%)

0.0118 (0.0205)

0.0061 (0.0092)

Sphingomonas

20 (90.9%)

20 (74.1%)

0.0356 (0.0786)

0.0105 (0.0179)

Geodermatophilaceae CI,0.80

20 (90.9%)

14 (51.9%)

0.019 (0.0282)

0.0043 (0.0096)

Bacillus

19 (86.4%)

12 (44.4%)

0.0069 (0.0117)

0.0034 (0.0068)

Rothia

19 (86.4%)

13 (48.2%)

0.0094 (0.0278)

0.0024 (0.0036)

Prevotella

18 (81.8%)

21 (77.8%)

0.0331 (0.0544)

0.0474 (0.1031)

Micrococcus

15 (68.2%)

16 (59.3%)

0.017 (0.0301)

0.0196 (0.0703)

Enhydrobacter

15 (68.2%)

6 (22.2%)

0.0045 (0.0055)

0.0008 (0.002)

Acinetobacter

14 (63.6%)

14 (51.9%)

0.0141 (0.0234)

0.0027 (0.0038)

Finegoldia

14 (63.6%)

14 (51.9%)

0.021 (0.0488)

0.0216 (0.0485)

Actinomyces

14 (63.6%)

16 (59.3%)

0.0166 (0.0547)

0.0086 (0.0188)

TM7 genera incertae sedis

14 (63.6%)

15 (55.6%)

0.0026 (0.0035)

0.0071 (0.0172)

Neisseria

14 (63.6%)

12 (44.4%)

0.0055 (0.0163)

0.0052 (0.0147)

Anaerococcus

13 (59.1%)

9 (33.3%)

0.0084 (0.0196)

0.0143 (0.0492)

Haemophilus

13 (59.1%)

16 (59.3%)

0.0074 (0.0182)

0.0141 (0.0232)

Porphyromonas

13 (59.1%)

10 (37.0%)

0.0176 (0.0458)

0.0133 (0.06)

Gemella

12 (54.6%)

10 (37.0%)

0.0029 (0.0046)

0.0026 (0.006)

Flavobacterium

12 (54.6%)

8 (29.6%)

0.0022 (0.004)

0.0016 (0.0041)

Massilia

12 (54.6%)

4 (14.8%)

0.0055 (0.0096)

0.0012 (0.0032)

Peptoniphilus

11 (50.0%)

11 (40.7%)

0.0091 (0.0294)

0.0125 (0.031)

Sphingomonas CI,0.80

11 (50.0%)

7 (25.9%)

0.0031 (0.007)

0.0005 (0.0008)

Microbacterium

11 (50.0%)

12 (44.4%)

0.002 (0.0039)

0.0012 (0.0038)

Pseudonocardia

11 (50.0%)

1 (3.7%)

0.0017 (0.0028)

0.0002 (0.0012)

Veillonella

10 (45.5%)

14 (51.9%)

0.0035 (0.0068)

0.0307 (0.0705)

Haemophilus CI,0.80

10 (45.5%)

17 (63.0%)

0.0021 (0.0035)

0.0094 (0.0258)

Singulisphaera

10 (45.5%)

10 (37.0%)

0.0042 (0.0091)

0.015 (0.0404)

Marmoricola

10 (45.5%)

6 (22.2%)

0.0009 (0.0016)

0.0008 (0.0019)

Cyanobacteria.GpI

9 (40.9%)

9 (33.3%)

0.022 (0.0693)

0.0042 (0.0094)

Pasteurella CI,0.80

9 (40.9%)

12 (44.4%)

0.0158 (0.0442)

0.0165 (0.0415)

Deinococcus

9 (40.9%)

10 (37.0%)

0.0066 (0.0253)

0.0009 (0.0019)

Marmoricola CI,0.80

9 (40.9%)

4 (14.8%)

0.0014 (0.0031)

0.0018 (0.0066)

Campylobacter

9 (40.9%)

10 (37.0%)

0.0173 (0.0444)

0.0238 (0.0705)

Paracoccus

8 (36.4%)

13 (48.2%)

0.0032 (0.0078)

0.0197 (0.0788)

Corynebacteriaceae CI,0.80

8 (36.4%)

5 (18.5%)

0.0009 (0.0018)

0.0004 (0.0011)

Bacillus CI,0.80

8 (36.4%)

4 (14.8%)

0.0005 (0.0009)

0.0003 (0.0005)

doi:10.1371/journal.ppat.1004262.t002

strongly associated with both semen bacterial load and blood HIV
viral load on univariate analysis (r2 = 0.45, p = 0.001 and r2 = 0.37,
p = 0.006, respectively). The total semen bacterial load remained
independently associated with semen VL in multivariate logistic
regression (t = 2.80, p = 0.007), while the association with blood
VL became borderline significant (t = 2.00, p = 0.05).
PLOS Pathogens | www.plospathogens.org

Discussion
The semen HIV RNA VL is a crucial measure of the
infectiousness of genital secretions in HIV-infected men. We had
hypothesized that microbiome-driven changes in semen immunology could impact the semen VL. In this study, we found
5
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semen bacteria, Streptococcus, are primarily associated with moist,
mucosal surfaces and are rare in the penile coronal sulcus [25]. In
contrast, Corynebacterium and Staphylococcus were common in
the semen of MSM and are also known inhabitants of skin and in
the coronal sulcus of circumcised men [25]. Thus, our findings
show that semen likely contains bacteria that originate from
multiple sites within the male genital tract.
There are a few limitations to our study. We did not collect
sexual behavior data, which would have allowed for interesting
additional analyses. However, it is unlikely that the alterations in
the semen microbiome diversity of HIV-infected men were due to
changes in sexual behavior, for two reasons. First, with the
exception of Prevotella, which can be found in multiple body sites
(including penile, vaginal, oral cavity, and gut) but can only have
limited effect on biodiversity as a single genus, we found a limited
overlap among semen, oropharyngeal, and gastrointestinal bacteria. Second, the increase in bacterial diversity was observed shortly
after ART initiation, during a period when patients had enhanced
medical follow-up and extensive counseling against unprotected
sex due to our own observations of isolated HIV shedding [27].
The methods used for semen processing were optimized for
detection of HIV in semen, and should be further refined for
future semen microbiome research. Specifically, our use of a high
centrifugation speed (850 g) might have differentially pelleted
bacterial species in semen, and our attempts to quantify bacteria in
the semen pellet were unsuccessful due to high levels of human
DNA that interfered with our method of bacterial DNA detection.
Therefore, future semen microbiome studies should consider lower
centrifugation speeds and methods to differentially extract
bacterial DNA from semen. The volume of semen should also
be recorded to enhance semen bacterial load analysis. Lastly, since
the hand and penile skin contain bacteria that could contaminate
semen samples, participants should be instructed to clean their
hands and penis prior to providing a semen sample.
We found the biodiversity of semen microbiome to be low as
compared to that previously described at other body sites [28] and
further reduced by HIV infection. From an ecological perspective,
this finding could reflect increased inter-bacterial competition as a
result of impaired local host immunity during HIV infection. After
ART initiation, the semen microbiome biodiversity was restored:
together with the correlation between CD4+ T-cell counts and
semen microbiome composition after ART, this suggests that local
host immunity plays a role in shaping the semen microbiome.
However, it is difficult to predict the relevance of this reduced
semen microbiome diversity to health outcomes in the host. While
reduced microbiome diversity has been associated with inflammation and negative health outcomes in the gastrointestinal tract
[29,30], reductions in the penis microbiome diversity after male
circumcision have been hypothesized to play a beneficial role in
the procedure’s protective effects against HIV acquisition [25].
Previous studies have linked elevated semen VL to sexual
practices such as unprotected insertive anal sex [7], which could
introduce gastrointestinal bacteria into the male urogenital
compartment and semen. Likewise, the finding of persistent semen
HIV shedding early after the initiation of effective ART suggest
that compartmentalized, non-treatment related factors such as the
semen microbiome could play a role in local shedding of HIV
[27]. In our study, all participants improved with treatment, as
evidenced by the rapid decreases in blood and semen VL. While
this highlights the effectiveness of ART, it will be important to
investigate the potential role of semen bacteria in mucosal
inflammation and the semen VL among ART-naı̈ve men,
particularly those whose semen VL is disproportionately higher
than that in blood [31,32]. It will also be important to evaluate a

Figure 2. Semen microbiome biodiversity in uninfected versus
HIV-infected men over the course of antiretroviral treatment.
In this set of two plots (Panels A–B), the solid circles represent HIVuninfected men, whereas open circles represent HIV-infected men.
Panel A depicts the higher richness (i.e., greater number of unique
bacterial types) of the semen microbiome in HIV-uninfected men, as
well as the restoration of richness over the period of six months on ART.
A similar trend was seen in semen microbiome diversity, as shown in
Panel B.
doi:10.1371/journal.ppat.1004262.g002

significant links between the semen bacterial load, the level of
semen pro-inflammatory cytokines and the semen HIV RNA VL.
In addition, our data demonstrated that HIV RNA shedding in
the semen correlated with increases in semen bacterial load and
IL-1b.
Since men who have sex with other men (MSM) are at
particularly high risk in the North American HIV epidemic, our
work focused on this population. Semen is a composite of
spermatozoa and secretions from the prostate, seminal vesicles,
and epididymis, and the precise sources of semen bacteria have
not yet been pinpointed. In particular, it is not clear whether these
bacteria are acquired from a partner during sexual intercourse or
originate from other host sites such as the urinary tract, gut or
foreskin. Earlier male urogenital bacterial studies have focused on
heterosexual men [18,19,22], where vaginal bacteria such as
Lactobacillus, Prevotella, Porphyromonas, Veillonella have been
shown in their semen, coronal sulcus, urethral, and urine [19,23–
25]. We observed that bacteria in the semen of MSM overlapped
with those previously described in the vagina, including Prevotella
and Mycoplasma; the latter, as well as Ureaplasma, has been
implicated in male infertility [26].
Our findings of Mollicutes in the semen of MSM, together with
previous reports in heterosexual men, suggest that semen is a
source for Mollicutes and may shed light on the directionality of
their sharing in heterosexual couples. Mollicutes and another
PLOS Pathogens | www.plospathogens.org
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Figure 3. Correlation of semen bacterial load with CD4+ T-cell counts and viral loads in the semen and blood of HIV-infected men
prior to antiretroviral treatment. Our data showed multiple correlations between HIV loads and CD4+ counts, including the correlation of semen
and blood viral loads and of blood CD4+ T-cell counts and viral load (Figure S1). However, we found that the significant correlation between semen
bacterial load with semen viral load was unique (Panel A), and the semen bacterial load showed no such correlation with either the blood viral load
(Panel B) or CD4+ T-cell counts (Panel C), suggesting that the correlation between bacterial and viral loads in the semen might be caused by localized
mechanisms.
doi:10.1371/journal.ppat.1004262.g003

samples form HIV-infected MSM prior to treatment and at
months 1 and 6 after initiation of standard-of-care antiretroviral
therapy.

possible role of semen bacteria in those men who maintain a
high semen VL despite effective ART [27]. Understanding the
role of semen bacteria in these contexts could shed new light on
HIV sexual transmission and lead to novel avenues for
prevention.
Our study showed that the semen bacterial load in HIV-infected
ART-naı̈ve men was correlated with the semen HIV VL and with
the levels of several pro-inflammatory cytokines in the semen;
among these, semen IL-1b levels were also correlated with semen
HIV VL. This suggests that semen bacteria, in the context of
untreated HIV infection, may induce a local inflammatory milieu
and drive increased HIV shedding and transmission, although the
restoration of reduced semen bacterial diversity post-ART implies
a reciprocal role for host immunity in shaping the semen
microbiome. While delineating the directionality and causality of
these complex relationships will require further studies, our data
support the hypothesis that semen bacteria play a role in local
inflammation and HIV shedding, and is a possible target for
reducing HIV transmission.

Sample collection and initial processing
Participants were instructed to abstain from intercourse and
masturbation for 48 hours prior to sample collection. Semen
samples were collected by masturbation into 10 mL sterile
RPMI 1640 containing 100 U/mL penicillin and 100 mg/mL
streptomycin (Gibco). Seminal plasma was isolated by centrifugation at 850 g for 10 minutes. Blood samples were
collected directly into acid citrate dextran and the blood
plasma was isolated by ficoll density gradient centrifugation at
500 g for 25 minutes. All samples were stored at 280uC until
analysis.

Chlamydia trachomatis, Neisseria gonorrhoeae, and
Treponema pallidum screening
Laboratory diagnosis of C. trachomatis or N. gonorrhoeae
urethritis was performed using seminal plasma by urine nucleic
acid amplification (Amplicor CT/NG assay, Roche Diagnostics,
QC, Canada). T. pallidum infection was determined by serology
(RPR; rapid plasma regain, BioRad, QC, Canada).

Methods
Ethics statement
Adult MSM, age 18–65, without physical or laboratory
evidence of C. trachomatis or N. gonorrhoeae or history of
T.pallidum infection were eligible to participate in the study.
HIV-infected, treatment-naı̈ve individuals were enrolled
through the Maple Leaf Medical Clinic in Toronto, Canada.
HIV-uninfected participants were volunteers recruited from
the staff and student body of University of Toronto. All study
participants provided written informed consent, and the study
was approved by the Research Ethics Board at the University
of Toronto (Toronto, Canada) (protocol #26946) and by
TGen’s IRB of record, the Western Institutional Review Board
(protocol # 20081375).

Blood and semen viral load quantification
Blood and semen HIV-1 RNA concentrations were measured
using the Versant HIV RNA 3.0 assay (bDNA Bayer Diagnostics,
Puteaux Cedex, France) in the Mount Sinai Hospital Department
of Microbiology. Correction for semen dilution was calculated
based on an average ejaculate volume of 2 mL, as described
previously [33].

Semen bacterial cell lysis and nucleic acid purification
We lysed 500 ml of thawed seminal plasma using a combination
of chemical and mechanical methods, purified using Qiagen
AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA, USA), and
the DNA was eluted in 100 ml of buffer EB, while RNA was eluted
in 50 ml. Reverse transcription was performed using qScript cDNA
SuperMix following the manufacturer’s instructions (Quanta
Biosciences, Geithersburg, MD, USA). Additional details can be
found in the Supplementary File.

Study design
This observational study of men who have sex with men (MSM)
in Toronto, Ontario, Canada examined the changes in the semen
microbiome associated with HIV infection and treatment with
antiretroviral therapy (ART) using a single semen specimen from
HIV-uninfected MSM as controls and paired blood and semen
PLOS Pathogens | www.plospathogens.org
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correlations between the semen microbiome composition and
semen bacterial load (log10), semen and blood viral loads, and
CD4+/CD8+ counts, we further examined these correlations by
vector fitting each variable as a vector or factor using the ordinated
ordination score matrix. We also evaluated if HIV infection status
has a global effect on semen microbiome composition by
permutational ANOVA [36]. A significance level of a = 0.05 was
used.
We evaluated the effects of HIV infection and ART on the
biodiversity of semen microbiome based on Diversity (D),
calculated as D = Shannon diversity index, evenness (E), calculated
as E = D/log(S), and S = richness [37]. Whereas richness represents the total number of unique taxa that have been detected,
evenness reflects the dominance by many (i.e., high evenness)
versus few (i.e., low evenness) taxa. The effect size of HIV infection
and of ART on each biodiversity metric, including the associated
95% CIs, was estimated by bootstrapping. Statistical significance
of the change after ART was determined by repeated measures
ANOVA.
We utilized indicator species analysis to identify the semen
bacteria that differed between uninfected men and HIV-infected,
untreated men. A significance level of a = 0.10 was used [38]. We
also extracted all Mollicute sequences from all positive samples
and examined the sequences using the SeqMan software
(DNASTAR Inc., Madison, WI, USA).

Semen bacterial load quantification and 16S rRNA-based
pyrosequencing analysis
Using the DNA fraction, we quantified the bacterial load,
measured as the bacterial 16S rRNA gene copy per ml of seminal
plasma using a broad-coverage qPCR assay [34]. Using the cDNA
fraction, we generated barcoded V3–V6 amplicons for pyrosequencing and processed the resultant sequence data as previously
described [25]. Additional details can be found in the Supplementary File.
Pyrosequencing yielded a total of 162,998 16S rRNA gene
sequences at $80% bootstrap confidence level after taxonomic
groups with fewer than ten sequences in the full dataset. For
sequence types that could not be further classified at $80%
bootstrap confidence level past a higher taxonomic level (e.g.,
Clostridiales), they were specified as ‘‘Unclassified’’ (e.g., Unclassified Clostridiales).

Seminal plasma cytokine quantification
We analyzed the cytokine/chemokine levels in 21 HIVuninfected participants and in 25 HIV-infected participants at
baseline. Cytokine and chemokine levels in seminal plasma were
measured using the Meso Scale Discovery SECTOR Imager 2400
(Meso Scale Discovery, Rockville, MD) multiplexing system
following manufacturer’s instructions. Using samples collected at
1:6 dilution, we measured 13 cytokines and chemokines including
interleukin (IL)-1a, IL-8, monocyte chemotactic protein-1 (MCP1), Monokine induced by gamma interferon (MIG), Macrophage
inflammatory protein-3 (MIP-3a), Regulated And Normal T-cell
Expressed and Secreted (RANTES), IL-10, IL-17, IL-1b, IL-6,
Interferon gamma-induced protein 10 (IP-10), MIP-1b and tumor
necrosis Factor alpha (TNF-a). Log10-transformed cytokine levels
were used in subsequent analysis.

Bacterial load analysis
The log10-transformed bacterial load data was used for all
statistical analyses. We evaluated the association of semen bacterial
load with HIV infection status and ART using the Wilcoxon
ranked-sum and signed-rank test, respectively. We further assessed
the relationship between semen bacterial load, the blood and
semen viral loads and CD4+ T-cell counts by univariate linear
regression and multivariate logistic models. Significance of
a = 0.05 was used.

HIV infection parameters in the infected group
We examined the change in CD4+ T-cell counts and semen and
blood viral loads in HIV-infected men at three time points.
Correlation between these three infection parameters were further
examined by linear regression in R version 2.13.1 [35]. All
subsequent analyses were performed in R, unless otherwise
specified.

Cytokine analysis
We built univariate linear regression models to examine the
correlation between semen cytokines and semen bacterial load
using a = 0.05. To address potential covariation among cytokines
that correlated significantly with semen bacterial load, we applied
principal component analysis with varimax rotation using the
psych package Version 1.3.10 in R [39]. The resultant threecomponent solution explained 93% of total variance. Lastly, we
examined the correlation of each component with semen viral load
by linear regression again using a = 0.05.

Microbiome analysis
We analyzed semen microbiome using genus-level data and two
primary metrics: prevalence and proportional abundance. Specifically, prevalence was calculated as: (Total number of participants
with more than two sequences for the genus A in group X)/(Total
number of participants in group X). Proportional abundance as:
(Number of sequences assigned to the genus A in participant A)/
(Total number of sequences from participant A).
After eliminating rare taxa detected at less than 1.5%
proportional abundance on a per-sample basis, we determined
the prevalence and proportional abundance of semen bacteria in
the uninfected controls and in HIV-infected MSM at three time
points. We compared top-ranked semen bacteria in each group
based on the sum of per-individual proportional abundance [36].
We visualized microbiome data using heatmap and non-metric
multidimensional scaling based on Bray-Curtis distance. Specifically, we converted the microbiome data matrix (measured in
semen bacteria proportional abundances) to a matrix based on
Bray-Curtis distance. We extracted the most informative components of the distance matrix by ordination (non-metric multidimensional scaling), and then fitted the variables of interest onto the
resultant ordination score matrix. Using this approach, we assessed
PLOS Pathogens | www.plospathogens.org

Supporting Information
Figure S1 Correlation of CD4+ T-cell counts with semen
and blood viral loads. Prior to antiretroviral therapy (ART),
the CD4+ T-cell counts were moderately correlated with blood
viral load (r2 = 0.27, p = 0.003), but not with the viral load in
semen. There was also a moderate correlation between the blood
and the semen viral load (r2 = 0.27, p = 0.003) (Panel A), but these
correlation did not persist after one (Panels B) or six months of
ART (Panel C).
(TIF)
Figure S2 Heatmap visualization of semen microbiome
in HIV-uninfected (n = 22) and HIV-infected men (n = 27)
based on proportional abundance. Each column in this
heatmap visualization shows the semen microbiome in each
sample, including in HIV-infected men over the course of their
treatment. Along each row, the proportional abundance each
8
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semen bacterial genus (e.g., Propionibacterium) is shown and can
be interpreted using the annotated color-coding key (right, color
bar), which denotes the color for its respective proportional
abundance. The heatmap shows a wide range of semen bacteria,
but few are more than 25% proportional abundant in a given
sample.
(TIF)

Figure S4 Changes in specific semen bacteria after one
and six months of ART. The semen bacterial changes after
ART did not involve those that were unique to HIV-uninfected
men. Pedobacter increased significantly in HIV-infected men after
ART (Panel A). Whereas among semen bacteria that were unique
to HIV-uninfected men, Enhydrobacter showed peaking after one
month of ART (Panel B) and Pseudonocardia peaking six months
of ART (Panel C). Bifidobacterium showed no appreciable
increase (Panel D).
(TIF)

Figure S3 Semen microbiome composition and its

correlation with semen bacterial load and CD4+ T-cell
counts in HIV-uninfected (n = 22) and HIV-infected men
(n = 27). In this set of non-metric multidimensional scaling plots
(Panels A–B), each data point represents the full semen
microbiome of a single sample. Panels A and B have the same
background nMDS plot, while in Panel A, the semen bacterial
load (log10-transformed) from each group was fitted as vector and
in Panel B, the CD4+ count was fitted. The corresponding Rsquare and p-value for each vector in each group is as shown. The
semen microbiome in HIV-uninfected men was correlated with
semen bacterial load, and this correlation was also seen in HIVinfected men prior to antiretroviral treatment (Panel A). However,
after six months of treatment, CD4+ T-cell counts became
significantly correlated with the semen microbiome (Panel B).
There was no overall composition difference between the semen
microbiome of HIV-uninfected men from men who are infected
by HIV, as shown by the overlapping 95% confidence interval
ellipses (Panel A–B).
(TIF)

Text S1 Supporting information. This file includes four
supporting information tables. Table S1. Prevalence and proportional abundances of semen bacteria in HIV-uninfected men and
in HIV-infected men prior to and after antiretroviral therapy.
Table S2. Results from the indicator analysis showing semen
bacterial genera based on HIV infection status. Table S3. Semen
bacteria unique in HIV-infected men after six months of
antiretroviral treatment. Table S4. Loadings from the principal
component analysis of pro-inflammatory cytokines that correlated
with semen bacterial load.
(DOCX)
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